KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $91.1 million.

  • Exact Sciences' Cash from Investing Activities rose 31760.84% to $91.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $195.1 million, marking a year-over-year increase of 14412.95%. This contributed to the annual value of $195.1 million for FY2025, which is 14412.95% up from last year.
  • As of Q4 2025, Exact Sciences' Cash from Investing Activities stood at $91.1 million, which was up 31760.84% from -$86.5 million recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' Cash from Investing Activities ranged from a high of $224.9 million in Q2 2025 and a low of -$793.8 million during Q2 2021
  • Its 5-year average for Cash from Investing Activities is -$60.3 million, with a median of -$38.2 million in 2024.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 1234148.9% in 2021, then soared by 31760.84% in 2025.
  • Over the past 5 years, Exact Sciences' Cash from Investing Activities (Quarter) stood at $78.4 million in 2021, then plummeted by 174.15% to -$58.2 million in 2022, then decreased by 14.8% to -$66.8 million in 2023, then soared by 37.29% to -$41.9 million in 2024, then soared by 317.61% to $91.1 million in 2025.
  • Its Cash from Investing Activities stands at $91.1 million for Q4 2025, versus -$86.5 million for Q3 2025 and $224.9 million for Q2 2025.